In summary, this study demonstrated that UBE2C is overexpressed in TMZ-resistant glioma tissues and cells and that the overexpression of UBE2C significantly enhances the resistance of glioma cells to TMZ by limiting p53 expression and facilitating aerobic glycolysis. The gene discussed is UBE2C; the disease is central nervous system cancer.